|
Development of cell-free DNA assays for HCC screening and liquid biopsy
|
1R01CA202769-01
|
$432,900
|
$432,900
|
SU, YING-HSIU
|
BARUCH S. BLUMBERG INSTITUTE
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
5R01CA190776-02
|
$636,299
|
$636,299
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel targets that are deregulated by loss of PTEN
|
5R01CA108614-10
|
$288,103
|
$288,103
|
JOHNSON, DEBORAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$5,901
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$8,545
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$5,944
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$24,997
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$6,711
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$162,656
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
1R01CA197081-01A1
|
$440,786
|
$149,867
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
$79,783
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
$27,500
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
$37,500
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-03
|
$9,068,022
|
$453,401
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Murine Models on SALL4 in Hepatocellular Carcinoma
|
5R03CA184531-02
|
$81,775
|
$81,775
|
CHAI, LI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Selenoproteins as targets for cancer prevention
|
4R01CA080946-16
|
$316,004
|
$316,004
|
GLADYSHEV, VADIM
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S1
|
$20,833
|
$208
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S2
|
$60,000
|
$600
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S3
|
$118,406
|
$1,184
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S4
|
$200,000
|
$2,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
4P30CA043703-26
|
$4,895,515
|
$48,955
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Injectable Implants for Increased Tumor Treatment Volume Using Pressure Driven Diffusion
|
5F31CA200373-02
|
$32,765
|
$32,765
|
HERNANDEZ, CHRISTOPHER
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Imaging Liver Cancer Proliferation
|
1R01CA204373-01
|
$321,679
|
$321,679
|
LEE, ZHENGHONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-03
|
$1,033,213
|
$25,830
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort
|
1R01CA204145-01A1
|
$440,818
|
$440,818
|
HUSSAIN, SHEHNAZ
|
CEDARS-SINAI MEDICAL CENTER
|
|
PROHIBITIN 1 IN LIVER INJURY AND CANCER
|
5R01CA172086-03
|
$312,404
|
$312,404
|
LU, SHELLY
|
CEDARS-SINAI MEDICAL CENTER
|
|
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors
|
5K08CA179084-03
|
$113,788
|
$56,894
|
YANG, SUN
|
CHAPMAN UNIVERSITY
|
|
The Mechanism of Tumor Formation in Beckwith-Wiedemann Syndrome
|
5K08CA193915-02
|
$140,504
|
$140,504
|
KALISH, JENNIFER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
CSHL Cancer Center Support Grant
|
2P30CA045508-29
|
$4,405,681
|
$88,114
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
4P01CA013106-45
|
$4,445,418
|
$222,271
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Cancer Center Support Grant
|
3P30CA013696-42S1
|
$120,000
|
$3,600
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S2
|
$60,000
|
$1,800
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S3
|
$121,873
|
$3,656
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S4
|
$150,866
|
$4,526
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S5
|
$199,541
|
$5,986
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S6
|
$500,000
|
$15,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-42
|
$3,792,720
|
$113,782
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
HMGB1 as Link Between Hepatocellular Injury and HCC
|
1R01CA200597-01A1
|
$458,761
|
$458,761
|
SCHWABE, ROBERT
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Hepatic Stellate Cells and Liver Cancer
|
5R01CA190844-02
|
$358,306
|
$358,306
|
SCHWABE, ROBERT
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA006516-51S1
|
$122,500
|
$1,225
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S2
|
$37,500
|
$375
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S3
|
$125,000
|
$1,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S4
|
$200,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S5
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S6
|
$199,953
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S7
|
$500,000
|
$5,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S8
|
$750,000
|
$7,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
4P30CA006516-51
|
$11,151,311
|
$111,513
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-03
|
$1,106,869
|
$27,672
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-03
|
$375,850
|
$4,698
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
Total relevant funding to Liver Cancer for this search: $75,693,176
|